Chief Scientific Officer; Director Lung Cancer Research Program Sarah Cannon Research Institute
Nashville, TN
Dr David Spigel reviews the results of key studies from 2020 on novel approaches to first- or second-line treatment of SCLC and mesothelioma with both existing and emerging agents.